» Articles » PMID: 2155045

Fear-motivated Behavior Induced by Prior Shock Experience is Mediated by Corticotropin-releasing Hormone Systems

Overview
Journal Brain Res
Specialty Neurology
Date 1990 Feb 12
PMID 2155045
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In earlier studies, we established that in rats, antagonism of corticotropin-releasing hormone (CRH) receptors reduced the occurrence of fear-motivated behavior displayed immediately after administration of electric foot shock. Because exposure to stress is reported to have long-term behavioral and physiological effects, we examined whether central administration of the synthetic CRH receptor antagonist, alpha-helical CRH(9-41), would also alter fear-motivated behavioral and hormonal responses occurring 24 h after exposure to electric foot shock. Adult male rats were placed in a shock box and administered three, 1.0 mA foot shocks. Twenty-four hours later, rats received an intracerebroventricular infusion of 20 micrograms of alpha-helical CRH(9-41) or vehicle 20 min before re-exposure to the shock box. Antagonism of CRH receptors produced a significant reduction in fear-motivated freezing. However, stress-induced analgesia and plasma adrenocorticotropin concentrations did not differ significantly from vehicle-treated animals. In order to assess whether the reduction in freezing was due to intrinsic actions of the CRH receptor antagonist, non-shocked rats received central infusions of alpha-helical CRH(9-41) prior to re-exposure to the test box. Under these conditions, behavior exhibited by antagonist- and vehicle-treated rats did not differ significantly. Results suggest that the reduction in fear-motivated behavior is mediated by antagonism of endogenous CRH receptors and occurs independently of analgesic and hormonal reactions induced by prior exposure to stress.

Citing Articles

PTSD and crime propensity: Stress systems, brain structures, and the nature of the relationship.

Svingen E Heliyon. 2023; 9(7):e18381.

PMID: 37519662 PMC: 10375856. DOI: 10.1016/j.heliyon.2023.e18381.


Dexamethasone facilitates fear extinction and safety discrimination in PTSD: A placebo-controlled, double-blind study.

Michopoulos V, Norrholm S, Stevens J, Glover E, Rothbaum B, Gillespie C Psychoneuroendocrinology. 2017; 83:65-71.

PMID: 28595089 PMC: 5524593. DOI: 10.1016/j.psyneuen.2017.05.023.


Corticotropin releasing factor type-1 receptor antagonism in the dorsolateral bed nucleus of the stria terminalis disrupts contextually conditioned fear, but not unconditioned fear to a predator odor.

Asok A, Schulkin J, Rosen J Psychoneuroendocrinology. 2016; 70:17-24.

PMID: 27153520 PMC: 4907900. DOI: 10.1016/j.psyneuen.2016.04.021.


Traits of fear resistance and susceptibility in an advanced intercross line.

McGuire J, Bergstrom H, Parker C, Le T, Morgan M, Tang H Eur J Neurosci. 2013; 38(9):3314-24.

PMID: 23968228 PMC: 5581004. DOI: 10.1111/ejn.12337.


Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety.

Sink K, Walker D, Freeman S, Flandreau E, Ressler K, Davis M Mol Psychiatry. 2012; 18(3):308-19.

PMID: 22290119 PMC: 3578178. DOI: 10.1038/mp.2011.188.